• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • PKR Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • ADK Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • PKR Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

NSP14 – A Promising SARS-CoV-2 Therapeutic Target

by Bellbrook Labs / Thursday, 20 January 2022 / Published in Emerging Targets, Innate Immunity
NSP14 - Coronavirus Target

Non-Structural Proteins of Coronaviruses

Coronaviruses have complex RNA-synthesizing machinery composed of many non-structural proteins (NSPs). While one-third of the viral genome encodes for structural proteins such as the spike, envelope, and nucleocapsid proteins, the remaining two-thirds encodes for NSPs. NSP genes are located within the 5’-region of the genome and studies have revealed that NSPs play essential roles in multiple viral processes such as RNA synthesis and processing¹.

The Two Faces of NSP14

NSP14 has recently been identified as an important NSP in SARS-CoV-2 virus replication. NSP14 is a unique bi-functional NSP that contains two functional domains – a 3’ to 5’ exoribonuclease (ExoN) at the N-terminus and a guanine-N7-methyltransferase (N7-MTase) domain at the C-terminus². The ExoN domain allows SARS-CoV-2 to proofread by catalyzing nucleoside monophosphate excision from nucleic acids, which is critical for high-fidelity replication. This is especially important for CoV to maintain its large RNA genome by decreasing the rate of harmful mutations. However, this proofreading capability of CoV has hindered the efficacy of antiviral ribonucleoside/ribonucleotide analogs such as remdesivir. Inactivating ExoN was shown to abolish the viability of SARS-CoV-2  effectively³. This is significant because targeting the ExoN activity of SARS-CoV-2 could potentially be an antiviral target for the treatment of COVID-19.

The N7-MTase domain of NSP14 is involved in mRNA capping. This is done by catalyzing the transfer of a methyl group from S-adenosyl-l-methionine (SAM) to the guanosine triphosphate moiety of the newly synthesized viral RNA, forming methylated capped RNA. This 5’ cap promotes RNA stability and translation by preventing degradation by exonucleases and also prevents detection by host innate antiviral responses4.

NSP14 and Innate Immune Responses

How does NSP14 allow CoV to evade host immune responses? 5’ RNA capping mediated by NSP14 allows CoV to mask the pathogen-associated molecular patterns (PAMPs) on the viral genome from being recognized by host immunity by mimicking eukaryotic RNA structures. Uncapped viral RNA is detected by host pattern recognition receptors, which will activate interferon (IFN)-associated antiviral immune responses5.

NSP14-NSP10 Protein-Protein Interactions

Additionally, NSP14 can form a complex with NSP10 (NSP14/10), where NSP10 aids in enhancing the ExoN activity of NSP14. A recent study found that NSP14/10 plays an essential role in inhibiting host translation, which promotes not only viral replication but also stifles immune responses6, therefore allowing CoV to better evade host immunity. Therefore, NSP14/10 poises as an attractive antiviral target to increase SARS-CoV-2  sensitivity towards host immune responses and increase the potency of existing antiviral pharmaceuticals.

References

  1. Yadav, R., Chaudhary, J. K., Jain, N., Chaudhary, P. K., Khanra, S., Dhamija, P., … & Handu, S. (2021). Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. Cells, 10(4), 821. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067447/
  2. Tahir, M. (2021). Coronavirus genomic nsp14‐ExoN, structure, role, mechanism, and potential application as a drug target. Journal of Medical Virology, 93(7), 4258-4264. https://pubmed.ncbi.nlm.nih.gov/33837972/
  3. Ogando, N. S., Zevenhoven-Dobbe, J. C., van der Meer, Y., Bredenbeek, P. J., Posthuma, C. C., & Snijder, E. J. (2020). The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. Journal of virology, 94(23), e01246-20. https://journals.asm.org/doi/10.1128/JVI.01246-20
  4. Decroly, E., Ferron, F., Lescar, J., & Canard, B. (2012). Conventional and unconventional mechanisms for capping viral mRNA. Nature Reviews Microbiology, 10(1), 51-65. https://www.nature.com/articles/nrmicro2675
  5. Li, J. Y., Zhou, Z. J., Wang, Q., He, Q. N., Zhao, M. Y., Qiu, Y., & Ge, X. Y. (2021). Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. Frontiers in Microbiology, 12. https://www.frontiersin.org/articles/10.3389/fmicb.2021.770656/full
  6. Hsu, J. C. C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B., & Cresswell, P. (2021). Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proceedings of the National Academy of Sciences, 118(24). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214666/
Tagged under: Innate Immunity, NSP14, Transcreener ADP Assay

What you can read next

Targeting Adenosine Kinase In the Fight Against Neurological Disorders
Targeting Adenosine Kinase in the Fight Against Neurological Disorders
PRMT5 Role with Macrophages
PRMT5 is Innately Interesting
TYK2 Inhibition Discovery
TYK2 Inhibition Finally Comes of Age

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Info book on cancer and RAFK1's relation

    RAF1 & Immunity: A Future Model For Cancer Research?

    RAF1, also known as c-Raf, is a member of the R...
  • OAS1 The Cost of Host Defense

    OAS1: The Cost of Host Defense

    OAS1 (Oligoadenylate synthetase 1) is induced b...
  • Scientist Studying DDX41

    DDX41 as a Sensor, Suppressor, and Modulator

    DDX41 [DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4...
  • Scientist Studying ALKPK1

    The Role of ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2022 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP